Skip to main content
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 2004 Mar 8;141(7):1131–1140. doi: 10.1038/sj.bjp.0705715

A critical ‘threshold' of β2-integrin engagement regulates augmentation of cytokine-mediated superoxide anion release

Trevor R Walker 1,2,*, Marie-Helene Ruchaud-Sparagano 1,2,3, Sarah R McMeekin 1, Ian Dransfield 1
PMCID: PMC1574883  PMID: 15006901

Abstract

  1. Neutrophil adhesion regulates a number of processes involved in the pathogenesis of inflammatory diseases including rheumatoid arthritis. Neutrophil destructive potential can be modulated by adhesion, allowing alteration of inflammatory cell behaviour while preserving antimicrobial defences. β2-Integrin-mediated neutrophil adhesion to albumin-coated latex beads (ACLB) allows modulation of integrin clustering and ligation and analysis of the effects of adhesion on neutrophil responses. Tumour necrosis factor-α (TNFα) enhanced neutrophil binding of different diameter ACLB equally, by almost four-fold, and independently of bead size. Adhesion of neutrophils to ACLB caused a size-dependent generation and release of O2 and also potentiated TNFα-induced O2 release.

  2. Binding of ACLB was not affected by disruption of cytoskeletal integrity with nocodazole or cytochalasin D or following blockade of tyrosine kinase activity. In contrast, tyrosine phosphorylation and an intact cytoskeleton were essential for adhesion- and cytokine-induced O2 release from neutrophils. Inhibition of adhesion- and cytokine-induced O2 release by 4-amino-5-(4-chlorophenyl)-7-(t-butyl)pyrazol[3,4-d]pyrimidine (PP2) indicated that a Src-family tyrosine kinase was the principal regulatory pathway mediating this response in neutrophils, a distal role for p38 MAPK was revealed by use of SB203580.

  3. Tyrosine phosphorylation of c-Fgr, a Src-family tyrosine kinase, occurred following ACLB adhesion and exposure to TNFα, and was susceptible to inhibition by PP2. We suggest that activation of the key regulatory enzyme c-Fgr is achieved following ligation of a critical threshold of integrins following binding of large (>3 μm) ACLB.

Keywords: Neutrophils, adhesion molecules, signal transduction

Introduction

The neutrophil granulocyte represents the vanguard of the cellular response to injury and infection (Haslett et al., 1989). Failure to recruit granulocytes results in inadequate clearance of microbes that can become life threatening (Anderson & Springer, 1987; Albelda et al., 1994). However, development of chronic inflammatory conditions with fibrotic repair mechanisms leading to compromised organ function is associated with excessive inflammatory cell recruitment or activation (Gailit & Clark, 1994). Thus, regulation of leukocyte recruitment and activation is critical for effective antimicrobial defences and efficient wound healing. Following rapid recruitment of neutrophils from the circulating pool of cells, a variety of microenvironmental stimuli induce rapid and specific mobilisation of granules that contain destructive enzymes and receptors for molecules of the innate and adaptive immune system, arming neutrophils for the recognition and removal of invading microorganisms (Borregaard & Cowland, 1997). This potent capacity for neutrophil-mediated destruction is very tightly regulated to ensure that inappropriate release of granule contents and superoxide, resulting in bystander damage to host tissue, is minimised. In addition, degranulation responses may be targeted to specific regions of the plasma membrane that are in close contact with target pathogens, further limiting potentially histotoxic effects (Owen & Campbell, 1995)

Many studies have examined ‘priming' of neutrophil effector function by combinations of inflammatory mediators providing specific mechanisms for amplification of release of destructive granule contents. For example, although exposure of neutrophils to PAF has little effect on granule release alone, in combination with formyl Met–Leu–Phe (fMLP), granule secretion responses are greatly augmented (Aida & Pabst, 1990). Recent studies have demonstrated that adhesion receptors are also coupled to the intracellular signal transduction machinery, providing ‘outside-in' signals that modulate leukocyte responses (Fashena & Thomas, 2000). Engagement of receptors that are involved in different stages of neutrophil recruitment have the potential to transduce signals that alter neutrophil behaviour, suggesting that the repertoire of receptors engaged on the neutrophil surface determines the functional responses in terms of adhesion, migration and secretion (Berton & Lowell, 1999). The functional alterations induced by adhesion receptors appear distinct from those caused by ‘priming' agents, which have little effect on generation of reactive oxygen species by themselves (Aida & Pabst, 1990). As an example, ligation of neutrophil L-selectin and P-selectin-glycoprotein-ligand-1 (PSGL-1) has been shown to augment β2-integrin-mediated adhesion and increase production of damaging reactive oxygen intermediates (Smolen et al., 2000). Selectin-dependent alterations in neutrophil function have been suggested to require co-stimulation with other agents, for example, platelet-activating factor (PAF) (Lorant et al., 1991; Ruchaud-Sparagano et al., 2000).

Studies in the 1980s demonstrated that adhesion to extracellular matrix components augmented release of degradative enzymes and toxic oxidant species (Nathan, 1987). Adherent neutrophils, in contrast to those in suspension, responded to secondary stimulation, for example, tumour necrosis factor-(TNFα) by the rapid and massive release of reactive oxygen species (Fuortes et al., 1999). Patients deficient in β2-integrins failed to show adhesion-dependent amplification mechanisms, suggesting that ligation of β2-integrins may induce specific signals that determine the extent of neutrophil activation (Nathan et al., 1989). Investigation of the mechanism by which integrin ligation promotes degranulation suggested that cytokines and integrins acted synergistically to decrease intracellular cAMP levels with protein kinase A acting as a negative regulator of granulocytes responses (Nathan & Sanchez, 1990). Tyrosine phosphorylation of key proteins through activation of tyrosine kinases is an important regulatory event in adhesion-dependent neutrophil activation (Fuortes et al., 1993). Use of the specific Src family kinase inhibitor, PP1 attenuated adhesion-dependent neutrophil degranulation, indicating a role for Src family tyrosine kinases (Mocsai et al., 1999). Further studies with double knockout p58(c-Fgr)−/−, p59/61(Hck)−/− animals also demonstrated defective adhesion-dependent responses, providing strong evidence that these kinases are involved. Examination of Fgr/Hck double knockout neutrophils showed a failure of spreading on extracellular matrix components, suggesting a strong link between the process of spreading and degranulation responses. Furthermore, one of the downstream targets of these Src family kinases, p72(Syk) was not phosphorylated (Lowell et al., 1996). Direct crosslinking of CD18 using antibodies fails to stimulate tyrosine phosphorylation of proteins that are important for the conversion of adhesion-dependent signalling and degranulation responses in Syk-deficient neutrophils (Yan & Berton, 1998). Activation of Src family kinases and Syk results in the activation of c-Cbl, Vav and Pyk-2 and redistribution of cytoskeletal proteins and components of the NADPH oxidase to a detergent insoluble fraction (Yan et al., 1997). Interestingly, neutrophil migration was not compromised in Syk-deficient animals, implying that migration is dependent upon signalling pathways from those involved in adherent activation. Furthermore, hck−/− fgr−/− lyn−/− neutrophils do not show impaired migration implying that β2-dependent migration relies on different signalling pathways than those involved in adherent activation (Mocsai et al., 2002). Thus, integrin-mediated trans-endothelial migration may be possible without triggering damaging release of granule contents.

We have exploited ligand-coated microparticles in a dynamic assay system to engage granulocyte β2-integrins in order to further examine the relative contribution of adhesion-dependent signals to neutrophil effector function. Our data suggest that there is a critical ‘threshold' requirement for integrin occupancy and clustering, necessary for the assembly and activation of downstream signalling cascades leading to augmentation of reactive oxygen species production and release. In particular, our findings suggest that integrin occupancy alone is unable to fully trigger neutrophil effector function and that additional signals associated with cytoskeletal rearrangements necessary for spreading are required.

Experimental procedures

Neutrophil isolation

Polymorphonuclear leukocytes (PMN) were isolated from peripheral blood of healthy donors as described previously (Dransfield et al., 1994). Briefly, after centrifugation of citrated whole blood at 300 g for 20 min and removal of platelet-rich plasma, leukocytes were separated from erythrocytes by dextran sedimentation using 0.6% dextran T500. PMN were then separated from mononuclear leukocytes using discontinuous isotonic Percoll gradients. PMN leukocytes were 95–98% neutrophils using morphological criteria, and viability was assessed by trypan blue exclusion.

Neutrophil adhesion to albumin-coated latex beads (ACLB)

β2-Integrin-dependent adhesion of ACLB to freshly isolated neutrophils was measured as described previously (Stocks et al., 1995). Fluorescent latex beads were washed in HBSS and incubated with human serum albumin (10 mg ml−1) for 15 min before washes in HBSS and resuspension at 0.5% in HBSS. Neutrophils, in the presence and absence of inhibitors as appropriate, were added to ACLB and agonist as described in figure legends. Cells (2.5 × 105) and ACLB (2.5 × 106), at a ratio of 1 : 10 for all bead sizes and to ensure that beads were in excess at all times, were then incubated at 37°C for 15 min in a shaking waterbath, at 110 beats min−1. After fixation of the cells with 0.5 ml of 0.5% glutaraldehyde, nonadherent ACLB were removed by three washes and bead binding to neutrophils was measured by flow cytometry. ACLB binding to neutrophils without phagocytosis was confirmed using the above method, utilising nonfluorescent beads and probing cell and bead suspensions with a monoclonal human albumin antibody (HSA-11, 1 : 500) and a FITC-conjugated secondary antibody (1 : 500) for 30 min at 4°C following fixation, bead binding was then analysed by flow cytometry.

Measurement of superoxide release

Determination of release of superoxide anions by freshly isolated neutrophils was performed as described previously (Condliffe et al., 1996). Briefly, neutrophils were preincubated with inhibitors as described in figure legends prior to addition of TNFα, in the presence of cytochrome c (1 mg ml−1), for 15 min at 37°C. Following this, the reaction was stopped by centrifugation (300 g, 5 min, 4°C) and the superoxide dismutase-inhibitable reduction of cytochrome c was determined for each supernatant by measuring the peak absorbance between 535 and 635 nm using a scanning spectrophotometer. Results are expressed as nanomoles of superoxide anions generated per 106 neutrophils.

Scanning electron microscopy

Following neutrophil adhesion to ACLB as indicated in figure legends, suspensions were transferred to clean glass coverslips by centrifugation at 300 g for 3 min and cells fixed in glutaraldehyde (3% v v−1) in sodium cacodylate buffer (0.1 M, pH 7.4) for 3 h. Coverslips were washed three times in sodium cacodylate buffer (0.1 M, pH 7.4) for 20 min each and transferred to osmium tetroxide (1% v v−1) in sodium cacodylate buffer (0.1 M, pH 7.4) for 1 h. Following a 30-min wash in distilled water, samples were dehydrated by sequential washes in increasing concentrations of acetone for 1 h each (50% v v−1, 70% v v−1, 90% v v−1), followed by three washes in acetone (100% v v−1) for 1 h each. Critical point drying with carbon dioxide was carried out and samples had a sputter coating of gold : palladium (20 nm, 60 : 40 w w−1) added prior to viewing by scanning electron microscopy.

Western blotting

Neutrophils were lysed, following stimulation as detailed in figure legends, in lysis buffer containing Tris HCl (100 mM, pH 8.0), NaCl (100 mM), EDTA (2 mM), Nonidet NP-40 (1% v v−1), Na3VO4 (5 mM), NaF (50 mM), protease inhibitor cocktail for 30 min at 4°C. Samples were centrifuged for 5 min at 13,000 g and supernatants were reduced with electrophoresis sample buffer containing Tris HCl (0.25 M, pH 6.8), sodium dodecylsulphate (8% w v−1), β-mercaptoethanol (10% w v−1), glycerol (30% v v−1) and bromophenol blue (0.02%). Samples for immunoprecipitation were incubated overnight at 4°C with shaking with a monoclonal antibody to c-Fgr following cell lysis, Pansorbin® cells were added for 1 h, immunoprecipitated pellets were washed and reduced in electrophoresis sample buffer. Reduced samples were subjected to 10% polyacrylamide gel electrophoresis (PAGE), Western blotted and probed with Rc20 (monoclonal antiphosphotyrosine antibody) and protein bands were visualised by enhanced chemiluminescence (ECL).

Statistical analysis

Analysis was carried out using the paired Student's t-test, differences considered to be significant when P<0.05.

Materials

Latex beads (1–10 μm) were purchased from Polysciences Inc. (Warrington, PA, U.S.A.), Dextran T500, Percoll and ECL reagents were purchased from Amersham Pharmacia Biotech (Buckingham, U.K.), cytochrome c and monoclonal anti-human albumin (HSA-11) were purchased from Sigma (Poole, U.K.), protease inhibitor cocktail was purchased from Life Tech (Paisley, U.K.), Pansorbin®, GF109203X, 4-amino-5-(4-chlorophenyl)-7-(t-butyl)pyrazol[3,4-d]pyrimidine (PP2), 4-amino-7-phenylpyrazol[3,4-d]pyrimidine (PP3), nocodazole and cytochalasin D were purchased from Merck Biosciences (Nottingham, U.K.), monoclonal antibodies against c-Fgr and phosphotyrosine were purchased from Upstate Biotech (Milton Keynes, U.K.), antibody 44 was a generous gift from Professor N Hogg, Leucocyte Adhesion Laboratory, ICRF (London, U.K.), antibody MHM23 was from Abcam (Cambridge, U.K.) and all other reagents were of analytical grade.

Results

ACLB binding induced superoxide (O2) release is dependent upon particle size

Our previous studies have shown that binding of ACLB to neutrophils occurs in a β2-integrin dependent manner following analysis by flow cytometry (Stocks et al., 1995). We utilised different bead sizes (1–10 μm) in order to ligate and localise integrins differentially on the neutrophil plasma membrane upon adhesion, in order to ascertain whether a ‘threshold' of integrin occupancy would induce a signalling event resulting in superoxide generation and release. In the absence of stimulation, a similar proportion of neutrophils (approximately 15%) were found to bind beads of either 1, 3 or 10 μm sizes. Stimulation with TNFα (20 ng ml−1) promoted ACLB binding to 75–80% of neutrophils in a manner that was independent of particle size (Figure 1a). In Mg2+-depleted buffer, binding of ACLB and O2 release was inhibited to control levels either in the presence and absence of TNFα, confirming that adhesion and adhesion-induced superoxide release were integrin-dependent (Figure 1). In contrast, when we examined O2 release following bead binding a differential effect of particle size was observed. Although binding of either 1 or 3 μm beads failed to induce O2 release above that observed under control conditions, 10 μm beads induced a significant increase in O2 release from 4.5±0.7 nmol 10−6 cells under control conditions to 12.6±0.9 nmol 10−6 cells (Figure 1b, P<0.01). Incubation of TNFα stimulated neutrophils with either 1 or 3 μm ACLB induced a small increase in O2 release when compared with TNFα alone. However, O2 release was significantly increased (approximately three-fold) in the presence of 10 μm ACLB (Figure 1b, P<0.01). This effect of 10 μm beads on O2 release was not simply additive with TNFα, implying that β2-integrin-mediated adhesion to a relatively large continuous surface acts synergistically with TNFα to augment effector function. In Mg2+-free buffer, the effect of ACLB binding to PMNs in the presence and absence of TNFα on O2 release and bead binding was inhibited thus confirming a requirement for functional integrins to mediate these adhesion-induced responses. The effect of the phorbol ester PMA, which activates protein kinase C directly and independently of integrins or cell surface receptors induced 68.2±4.7 nmol 10−6 cells O2 release, which was unaffected by ACLB binding (data not shown). Figure 2 shows the effect of β2-integrin-specific function blocking antibodies MHM23 and 44 to inhibit significantly fMLP-stimulated neutrophil binding to 1 μm ACLB by 89.9±2.6 and 85.1±1.5% respectively, thus confirming that neutrophil adhesion to ACLB is β2-integrin-dependent.

Figure 1.

Figure 1

Binding of ACLB to human neutrophils induces superoxide release. (a) Cells in HBSS were treated with vehicle (open bars) or TNFα (20 ng ml−1, horizontally hatched bars) or in Mg2+-depleted HBSS (vehicle, obliquely hatched bars; TNFα, filled bars) for 15 min prior to addition of various sizes of ACLB (1–10 μm) as indicated, for a further 15 min at 37°C and shaken at 110 beats min−1, and ACLB binding analysed by flow cytometry. Results are expressed as % PMN binding to ACLB±s.e.m., results are from three experiments each performed in duplicate. (b) Cells were treated as indicated in (a), reactions were carried out at 37°C under shaking conditions and superoxide release determined by cytochrome c reduction as detailed in Methods. Results are expressed as nmol superoxide released 10−6 cells±s.e.m., from 24 experiments carried out in duplicate.

Figure 2.

Figure 2

Binding of ACLB to neutrophils is β2-integrin-dependent. Cells in HBSS were treated as indicated with β2-integrin-blocking antibodies MHM23 and 44, at maximally effective concentrations as determined in functional assays (data not shown), for 15 min prior to addition of fMLP (10 nM). ACLB (1 μm) were added for a further 15 min at 37°C and shaken at 110 beats min−1, and ACLB binding was analysed by flow cytometry. Results are expressed as % PMN binding to ACLB±s.e.m., results are from three experiments each performed in duplicate.

Scanning electron microscopy confirmed that ACLB (1–10 μm) were bound to the surface of neutrophils and not phagocytosed following adhesion (Figure 3a–c), implying that loss of smaller beads from the external cell surface by phagocytosis does not account for their inability to induce O2 release. A monoclonal Ab specific for albumin was used to detect surface-bound but not internalised beads by flow cytometry. These experiments confirmed that ACLB (1–10 μm) were localised to the cell surface and that the extent of binding was similar for each size of ACLB (Figure 4a). Neutrophils treated with TNFα showed increased surface binding of ACLB, independently of size (Figure 4b), both observations being consistent with our results obtained with fluorescent ACLB binding to neutrophils (Figure 1a).

Figure 3.

Figure 3

Scanning electron microscopy of neutrophils adhering to ACLBs. Cells were incubated with ACLB (a) 1 μm, (b) 3 μm, (c) 10 μm for 15 min at 37°C and shaken at 110 beats min−1, cell suspensions were transferred to glass coverslips, processed and examined by scanning electron microscopy as described in Experimental procedures.

Figure 4.

Figure 4

Neutrophil cell surface-bound ACLBs detected by flow cytometry. (a) Flow cytometric analysis of ACLB binding was carried out as in Figure 1, using nonfluorescent beads and a monoclonal human albumin antibody to detect binding of beads to the neutrophil surface. (b) ACLB binding in the presence and absence of TNFα (10 ng ml−1) was carried out and analysed as detailed in (a). Results are expressed as fold increase in ACLB binding±s.e.m., above control fluorescence detected with cells in the absence of ACLB, results are from individual observations from three experiments.

ACLB-induced O2 release requires cytoskeletal integrity

These data led us to consider the hypothesis that localisation and clustering of occupied integrins above a certain ‘threshold' level generates signals that result in potentiation of TNFα-induced O2 release. We therefore used nocodazole (5 μM) and cytochalasin D (5 μM), which are known to be selective concentrations at disrupting either microtubule dynamics or actin microfilaments respectively (Howard et al., 1981; Zaslaver et al., 2001). Interestingly, these treatments had no significant effect on binding of ACLB (1–10 μM) to neutrophils, indicating that integrin functionality was not compromised (Figure 5a and 6a). Both nocodazole and cytochalasin D were found to inhibit partially TNFα and ACLB-potentiated TNFα-induced O2 release (Figure 5b and 6b), confirming a role for intact cytoskeletal elements in providing scaffolding for the formation of signalling complexes to mediate O2 generation in response to both cytokines and adhesion events.

Figure 5.

Figure 5

Release of superoxide upon ACLB binding requires intact microtubules. (a) Cells were treated with nocodazole (5 μM, hatched bars) or vehicle (open bars) for 10 min after addition of TNFα (20 ng ml−1) and ACLB (10 μm) for 15 min as indicated and superoxide release measured as described before. Results are expressed as nmol superoxide released 10−6 cells±s.e.m., from three experiments carried out in duplicate. (b) Cells were treated as for (a) and binding to ACLB (10 μm) was analysed by flow cytometry as described before. Results are expressed as % PMN binding to ACLB±s.e.m., from three experiments carried out in duplicate.

Figure 6.

Figure 6

Release of superoxide upon ACLB binding requires intact actin microfilaments. (a) Cells were pretreated with cytochalasin D (5 μM, hatched bars) or vehicle (open bars) for 10 min for 37°C after addition of TNFα (20 ng ml−1) and ACLB (10 μm) for 15 min as indicated, superoxide release measured as described before. Results are expressed as nmol superoxide released 10−6 cells±range, from one experiment, representative of two others with similar results. (b) Cells were treated as for (a) and binding to ACLB (10 μm) analysed by flow cytometry a described before. Results are expressed as % PMN binding to ACLB±s.e.m., from three experiments carried out in duplicate.

Tyrosine phosphorylation is required for ACLB-induced O2 release

Binding of ACLB to neutrophils appears to be PKC-independent, as the specific inhibitor GF109203X had no significant effect on ACLB (10 μm) binding in the presence and absence of TNFα (Figure 7a). In addition, O2 release induced by TNFα in the presence of bound ACLB (10 μm) was not significantly inhibited by GF109203X whereas PMA-induced O2 release was inhibited by 75±14% (Figure 7b). These data suggest that PKC activation and resulting serine and threonine phosphorylation of its substrates is not required for integrin-mediated potentiation of superoxide release. In contrast, a role for tyrosine kinases in mediating the signalling events that regulate superoxide release in neutrophils subsequent to receptor activation, integrin occupancy and clustering was suggested by the ability of genistein (50 μM) to inhibit completely O2 release induced by TNFα in the presence and absence of bound ACLB (Figure 7b). Genistein, a selective tyrosine kinase inhibitor (IC50 2.6 μM) (Liles et al., 1995) had no effect on ACLB binding to neutrophils under control and TNFα-stimulated conditions (Figure 7a) ruling out an effect on integrin ligation directly. Importantly, as shown in Figure 7b, genistein was not able to block superoxide release induced through direct activation of protein kinase C by PMA, ruling out a direct effect on assembly of the NADPH oxidase. Further experiments using the Src family tyrosine kinase inhibitor PP2, at a known selective concentration (IC50 0.6 μM) (Salazar & Rozengurt, 1999), revealed inhibition of O2 release induced by binding of ACLB (10 μm) in the presence or absence of TNFα to below control levels (Figure 8a). PP2 had no effect on PMA-induced O2 release and PP3, an inactive structural analogue of PP2, also had no effect on ACLB, TNFα or PMA-induced O2 release (data not shown). These data suggest an obligatory role for an Src-family tyrosine kinase in mediating O2 release induced by both ACLB binding, through integrin occupancy and clustering, and by TNFα. Our observations also implicate an Src-family tyrosine kinase at a point of convergence of the signalling pathways initiated by the TNFα receptor and β2-integrins, which act synergistically to induce O2 release in neutrophils.

Figure 7.

Figure 7

Release of superoxide upon ACLB binding requires tyrosine phosphorylation. (a) Cells were treated with vehicle, TNFα (20 ng ml−1) for 20 min prior to addition of GF109203X (oblique hatched, 5 μM) or genistein (horizontally hatched, 50 μM) for 10 min. Cells were then adhered to ACLB (10 μm) under shaking conditions at 37°C for 15 min and ACLB binding analysed by flow cytometry. Results are expressed as % PMN binding to ACLB±s.e.m., from three experiments carried out in duplicate. (b) Cells were treated with vehicle, TNFα (20 ng ml−1) or PMA (10 nM) and inhibitors as detailed in (a) and superoxide release measured as described before. Results are expressed as nmol superoxide released 10−6 cells±s.e.m., from three experiments carried out in duplicate.

Figure 8.

Figure 8

Adhesion-induced superoxide release requires Src family kinases and p38 MAP kinase. (a) Cells were treated with PP2 (5 μM, hatched bars) or vehicle (open bars) for 15 min prior to addition TNFα (20 ng ml−1) and ACLB (10 μm) as indicated for 15 min and superoxide release measured as described before. Results are expressed as nmol superoxide released 10−6 cells±s.e.m., from three experiments carried out in duplicate. (b) Cells were treated with TNFα (20 ng ml−1) and ACLB (10 μm) as indicated and whole-cell lysates analysed by Western blotting using p38 MAPK and phospho-p38 MAPK antibodies. (c) Cells were treated with SB203580 (10 μM, hatched bars) or vehicle (open bars) for 10 min prior to addition of TNFα (20 ng ml−1) and ACLB (10 μm) for 15 min and superoxide release measured as described before. Results are expressed as nmol superoxide released 10−6 cells±s.e.m., from three experiments carried out in duplicate.

As p38 MAPK has previously been implicated in regulating release of primary and secondary granules from neutrophils in an Src-family tyrosine kinase-dependent manner (Mocsai et al., 2002), we examined whether p38 MAPK was a potential downstream target of Src-family kinases in the pathway mediating O2 release. Adhesion of neutrophils to ACLB (10 μm) caused a modest increase in the active phosphorylated form of p38 MAPK, whereas TNFα induced a significant increase in the active form of p38 MAPK, which was not further increased upon subsequent adhesion to ACLB (Figure 8b). A role for p38 MAPK as a potential downstream target of Src-family kinases in the pathway mediating O2 release as identified was identified by the ability of SB203580 (10 μM), a concentration known to be maximally effective in neutrophils and to have no effect on the formation of the NADPH oxidase (Cuenda et al., 1995; Lal et al., 1999), to partially inhibit O2 release induced by TNFα and bound ACLB (10 μm) from neutrophils (Figure 8c).

Binding of ACLB induces tyrosine phosphorylation of Fgr

In view of the above data suggesting involvement of Src family kinases in mediating the ACLB-induced O2 response of neutrophils, we next examined patterns of tyrosine phosphorylation in neutrophils. Adhesion of ACLB (10 μm) to neutrophils induced tyrosine phosphorylation of a protein of approximately 56–58 kDa, as detected in whole-cell lysates (Figure 9a). Tyrosine phosphorylation of this protein was dependent on ACLB particle size, implicating the extent of integrin occupancy and clustering as a regulating factor in the level of tyrosine kinase activity and phosphorylation status of this protein. Treatment of neutrophils with TNFα only induced a modest increase in tyrosine phosphorylation of this protein above control levels, but in the presence of TNFα and adhesion to ACLB (10 μm), there was a dramatic potentiation of the tyrosine phosphorylation of this 56–58 kDa protein, apparently correlating with the level of induced O2 release (Figure 9a).

Figure 9.

Figure 9

Adhesion induces tyrosine phosphorylation of Fgr. (a) Cells were incubated with TNFα (20 ng ml−1) for 15 min prior to addition of ACLB (1–10 μm) for 15 min at 37°C as indicated. Western blots of whole-cell lysates were probed with Rc20 (antiphosphotyrosine) and visualised with ECL, molecular weight markers are as indicated. The tyrosine-phosphorylated protein of interest is indicated with an arrow. (b) Cells were incubated with TNFα (20 ng ml−1) for 15 min prior to addition of ACLB (10 μm) for 15 min at 37°C as indicated. Cells were immunoprecipitated with a monoclonal antibody to c-Fgr, Western blotted, probed with Rc20 (antiphosphotyrosine) and visualised with ECL, c-Fgr is indicated.

Immunoprecipitation of one potential candidate, the Src-family tyrosine kinase Fgr showed that this enzyme became tyrosine phosphorylated in response to TNFα, adhesion to ACLB (10 μm) also resulted in tyrosine phosphorylation of Fgr and in combination resulted in potentiation of this phosphorylation (Figure 9b). Furthermore, tyrosine phosphorylation of Fgr following activation by TNFα and adhesion to ACLB was sensitive to inhibition by PP2, consistent with the suggestion that either autophosphorylation of c-Fgr or phosphorylation of c-Fgr via a related tyrosine kinase was required for translation of adhesion-dependent signals to augmentation of superoxide release (Figure 9b).

Discussion

In this study we have shown that the ability of PMN to initiate a respiratory burst and release of superoxide can be potentiated by β2-integrin-mediated adhesion to ACLB, in a size-dependent manner. The novel approach in which ACLB have similar ligand density has allowed exposure of cells to regulated levels of adherent substrate of defined surface area, enabling limitation of the extent of integrin engagement associated with neutrophil adhesion. As previously demonstrated, β2-integrin-dependent ACLB adherence to neutrophils was found to be enhanced in the presence of TNFα (Young et al., 1990), suggesting that an ‘inside-out' modulation of integrin activity accounts for promotion of adhesion (Condliffe et al., 1996). Increased integrin adhesion following cytokine stimulation has been previously shown to occur independently of changes in cell surface expression of β2-integrins (Vedder & Harlan, 1988; Schleiffenbaum et al., 1989). Consistent with this suggestion, our data show that neutrophil adhesion to both 1 and 10 μm ACLB was promoted to the same extent by TNFα, suggesting that differential integrin ligation was not the major factor involved in the regulation of superoxide responses. We present evidence that particle size and by implication localisation of integrins involved in adhesion plays a critical role in potentiation of TNFα-induced superoxide release. Binding of larger 10 μm particles were able to induce superoxide release and importantly to potentiate the TNFα dependent superoxide responses, presumably through ligating and clustering sufficient integrins to single sites of adhesion to form a competent signalling complex. In contrast, multiple 1 μm β2-integrin ligand-coated particles would ligate numerous patches of integrins over the neutrophil surface, but we hypothesise that insufficient clustering fails to form signalling complexes and an inability to trigger superoxide release. Importantly, these smaller beads remain bound to the neutrophil plasma membrane and are not internalised, as shown by scanning electron microscopy and flow cytometry; therefore, the inability of smaller beads to induce O2 release is not due to phagocytosis and phagosomal membrane closure resulting in termination of integrin signalling. These data demonstrate that a ‘threshold' effect of integrin engagement and clustering occurs in neutrophils that may determine the extent of response to cytokines and adhesion-dependent signals.

Interestingly, our studies show that integrin engagement per se does not trigger enhancement of superoxide responses to a second agonist. It is now well established that integrin engagement leads to the assembly of adhesion-dependent signalling complexes, containing components such as Src family kinases (Lowell & Berton, 1999). Use of specific inhibitors of cytoskeletal regulation such as nocodazole and cytochalasin D revealed that augmented O2 release could be blocked without influencing particle binding. These inhibitors also showed that there is a small degree of O2 release from neutrophils in suspension, being mediated by constitutive signalling events and cytoskeletal dynamics or may involve transient neutrophil/neutrophil interactions under these conditions. Previous reports have shown that cytoskeletal disruption with cytochalasin D (5 μM) could inhibit leukocyte motility and phagocytosis implying the necessity of cytoskeletal function for cellular responses (Howard et al., 1981). Our data therefore suggest that a competent cytoskeleton may be required for delivery, formation and functional coupling of signalling complexes to the site of particle adhesion (van Spriel et al., 2001), necessary for enhanced production of reactive oxygen species in response to TNFα. Previous studies indicate a critical requirement for cytoskeletal structures in spreading neutrophil adhesion (Sheikh et al., 1997) and there is a close association between the cytoskeleton and superoxide release from neutrophils (el Benna et al., 1994). Since we have demonstrated that neutrophil adhesion to ACLB occurs independently of cytoskeletal reorganisation and microtubule reassembly this may represent a useful model to allow dissociation of integrin-mediated adhesion events from the process of cell spreading. Our data suggest that in addition to integrin-mediated recruitment of effector molecules (Yan & Berton, 1998) further cytoskeletal reorganisation is required for the formation of a competent signalling complex that mediates superoxide generation in response to both cytokines and adhesion. One possibility is that active participation of the microfilament and microtubule networks within neutrophils directs movement of signalling proteins or effector molecules to sites of integrin interaction (van Spriel et al., 2001).

Tyrosine kinase activation has been reported to be required for cytoskeletal rearrangement essential for neutrophil spreading and strengthening of adhesion and migration (Gaudry et al., 1992; Takami et al., 2001). Experiments using the selective protein kinase C inhibitor GF109203X demonstrate that protein kinase C does not have a role in ACLB binding and TNFα-induced O2 release. TNFα has been shown to induce tyrosine phosphorylation of a number of proteins in neutrophils in an adhesion-dependent manner, resulting in recruitment of proteins to adhesion contacts (Fuortes et al., 1993). For neutrophils adherent to 10 μm ACLB, we have demonstrated an obligate role for tyrosine phosphorylation since genistein, a selective tyrosine kinase inhibitor (Liles et al., 1995), resulted in almost complete inhibition of O2 release induced by TNFα. However, ACLB binding was not affected, implying that genistein inhibits assembly of signalling complexes and cytoskeletal reorganisation required for spreading adhesion in neutrophils as suggested by Fuortes et al. (1993). Inhibition of O2 release by genistein from unstimulated neutrophils in suspension indicates that a degree of constitutive signalling occurs under these conditions and involves the same pathways that are involved in adhesion- and cytokine-induced activation. This small degree of ‘constitutive' activation may reflect neutrophil/neutrophil adhesive interactions in suspension as unstimulated O2 release was also inhibited by removal of Mg2+ and may therefore involve integrin activation. We have demonstrated that Fgr, a Src-family tyrosine kinase, undergoes tyrosine phosphorylation upon adhesion of ACLB and that adhesion-induced O2 release requires Src-family tyrosine kinase activity and integrin functional competency. Whether Fgr undergoes autophosphorylation or is phosphorylated by a related tyrosine kinase remains to be confirmed. These findings are consistent with studies in murine neutrophils, for which the Src family kinases Fgr, Hck and Lyn are critical (Mocsai et al., 2000).

A number of candidate downstream effectors of Src-family tyrosine kinases have been identified but their respective roles have not yet been fully characterised. The tyrosine kinase Syk is recruited to the cytoskeleton in an Src-dependent manner following β2-integrin ligation and neutrophils from Syk−/− mice did not undergo adhesion or activation following ligation of β2-integrins (Mocsai et al., 2002). Activation of p38 MAPK and subsequent granule release from neutrophils by fMLP has also been shown to be a downstream target of Src-family kinases and Syk (Mocsai et al., 2002). This study and others (Waterman et al., 1996) have shown that TNFα induces activation of p38 MAPK in neutrophils, and also adhesion caused a partial activation of this signalling enzyme. Direct inhibition of p38 MAPK partially reduced release of primary and secondary granules, thus implicating this pathway as a possible regulatory event (Mocsai et al., 2002). Our data show partial inhibition of adhesion-induced superoxide release in the presence and absence of TNFα by the p38 MAPK inhibitor SB203580, implicating this pathway as a possible downstream target of Fgr. In agreement, SB203580, in a concentration-dependent manner, has also been shown to only partially inhibit fMLP- and PMA-induced O2 release without affecting assembly of the NADPH oxidase (Lal et al., 1999) However, the p38 MAPK pathway must act in parallel with a distinct signalling pathway that is insensitive to SB203580 to regulate the extent of adherent neutrophil responses. Interestingly, ligation of L-selectin on neutrophils has been shown to lead to β2-integrin regulation and activation of p38 MAPK and ERK1/2, demonstrating a potential mechanism where adhesion to L-selectin can recruit and amplify signals transduce via β2-integrin activation (Green et al., 2002).

A sequential model in which engagement of β2-integrins using monoclonal antibodies induced integrin-dependent cytoskeletal rearrangement resulting in signalling complex formation between cytoskeletal proteins and tyrosine kinases, leading to de novo actin-polymerisation and tyrosine kinase activation, has been proposed (Yan & Berton, 1998). Based on our observations, we would suggest that integrin ligation with ACLB promotes activation events through β2-integrins that involve microtubule and microfilament reorganisation and redistribution of the MTOC and the Golgi within neutrophils. The kinetics of adhesion-dependent signalling protein recruitment are complex but require in part a reorganised cytoskeleton to provide a framework for the targeted delivery of membrane vesicles containing specific membrane proteins and enzymes, together with Src-family tyrosine kinases to regulate the extent of neutrophil activation. The ability of neutrophils to release O2, although to a limited extent, in the presence of agents that disrupt actin assembly and microtubules suggest that key signalling components may be dynamically moved to and away from sites of integrin activation. Tyrosine phosphorylation and activation of Fgr is an obligatory step in the regulation of neutrophil O2 release and may integrate activation inputs from both integrins and TNF receptors to mediate the potentiation of O2 release from neutrophils.

Acknowledgments

This work was funded by the Arthritis Research Campaign, UK. SR McMeekin is an MRC Research Student. We thank Stephen Mitchell for help with electron microscopy.

Abbreviations

ACLB

albumin-coated latex beads

ECL

enhanced chemiluminescence

fMLP

formyl Met–Leu–Phe

PAF

platelet-activating factor

PAGE

polyacrylamide gel electrophoresis

PMN

polymorphonuclear leokocytes

PP2

4-amino-5-(4-chlorophenyl)-7-(t-butyl)pyrazol[3,4-d]pyrimidine

PP3

4-amino-7-phenylpyrazol[3,4-d]pyrimidine

PSGL-1

P-selectin-glycoprotein-ligand-1

TNFα

tumour necrosis factor-α

References

  1. AIDA Y., PABST M.J. Priming of neutrophils by lipopolysaccharide for enhanced release of superoxide. requirement for plasma but not for tumor necrosis factor-alpha. J. Immunol. 1990;145:3017–3025. [PubMed] [Google Scholar]
  2. ALBELDA S.M., SMITH C.W., WARD P.A. Adhesion molecules and inflammatory injury. FASEB J. 1994;8:504–512. [PubMed] [Google Scholar]
  3. ANDERSON D.C., SPRINGER T.A. Leukocyte adhesion deficiency: an inherited defect in the Mac-1, LFA-1, and P150,95 glycoproteins. Annu. Rev. Med. 1987;38:175–194. doi: 10.1146/annurev.me.38.020187.001135. [DOI] [PubMed] [Google Scholar]
  4. BERTON G., LOWELL C.A. Integrin signalling in neutrophils and macrophages. Cell Signal. 1999;11:621–635. doi: 10.1016/s0898-6568(99)00003-0. [DOI] [PubMed] [Google Scholar]
  5. BORREGAARD N., COWLAND J.B. Granules of the human neutrophilic polymorphonuclear leukocyte. Blood. 1997;89:3503–3521. [PubMed] [Google Scholar]
  6. CONDLIFFE A.M., CHILVERS E.R., HASLETT C., DRANSFIELD I. Priming differentially regulates neutrophil adhesion molecule expression/function. Immunology. 1996;89:105–111. doi: 10.1046/j.1365-2567.1996.d01-711.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. CUENDA A., ROUSE J., DOZA Y.N., MEIER R., COHEN P., GALLAGHER T.F., YOUNG P.R., LEE J.C. SB 203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin-1. FEBS Lett. 1995;364:229–233. doi: 10.1016/0014-5793(95)00357-f. [DOI] [PubMed] [Google Scholar]
  8. DRANSFIELD I., BUCKLE A.M., SAVILL J.S., MCDOWALL A., HASLETT C., HOGG N. Neutrophil apoptosis is associated with a reduction in CD16 (Fc Gamma RIII) expression. J. Immunol. 1994;153:1254–1263. [PubMed] [Google Scholar]
  9. EL BENNA J., RUEDI J.M., BABIOR B.M. Cytosolic guanine nucleotide-binding protein Rac2 operates in vivo as a component of the neutrophil respiratory burst oxidase. Transfer of Rac 2 and the cytosolic oxidase components P47phox and P67phox to the submembranous actin cytoskeleton during oxidase activation. J. Biol. Chem. 1994;269:6729–6734. [PubMed] [Google Scholar]
  10. FASHENA S.J., THOMAS S.M. Signalling by adhesion receptors. Nat. Cell Biol. 2000;2:E225–E229. doi: 10.1038/35046654. [DOI] [PubMed] [Google Scholar]
  11. FUORTES M., JIN W.W., NATHAN C. Adhesion-dependent protein tyrosine phosphorylation in neutrophils treated with tumor necrosis factor. J. Cell Biol. 1993;120:777–784. doi: 10.1083/jcb.120.3.777. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. FUORTES M., MELCHIOR M., HAN H., LYON G.J., NATHAN C. Role of the tyrosine kinase Pyk2 in the integrin-dependent activation of human neutrophils by TNF. J. Clin. Invest. 1999;104:327–335. doi: 10.1172/JCI6018. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. GAILIT J., CLARK R.A. Wound repair in the context of extracellular matrix. Curr. Opin. Cell Biol. 1994;6:717–725. doi: 10.1016/0955-0674(94)90099-x. [DOI] [PubMed] [Google Scholar]
  14. GAUDRY M., CAON A.C., GILBERT C., LILLE S., NACCACHE P.H. Evidence for the involvement of tyrosine kinases in the locomotory responses of human neutrophils. J. Leukocyte Biol. 1992;51:103–108. doi: 10.1002/jlb.51.2.103. [DOI] [PubMed] [Google Scholar]
  15. GREEN C.E., PEARSON D.N., CHRISTENSEN N.B., SIMON S.I. Topographic requirements and dynamics of signaling via L-selectin on neutrophils. Am. J. Physiol. Cell Physiol. 2002;284:C705–C717. doi: 10.1152/ajpcell.00331.2002. [DOI] [PubMed] [Google Scholar]
  16. HASLETT C., SAVILL J.S., MEAGHER L. The neutrophil. Curr. Opin. Immunol. 1989;2:10–18. doi: 10.1016/0952-7915(89)90091-5. [DOI] [PubMed] [Google Scholar]
  17. HOWARD T.H., CASELLA J., LIN S. Correlation of the biologic effects and binding of cytochalasins to human polymorphonuclear leukocytes. Blood. 1981;57:399–405. [PubMed] [Google Scholar]
  18. LAL A.S., CLIFTON A.D., ROUSE J., SEGAL A.W., COHEN P. Activation of the neutrophil NADPH oxidase is inhibited by SB 203580, a specific inhibitor of SAPK2/P38. Biochem. Biophys. Res Commun. 1999;259:465–470. doi: 10.1006/bbrc.1999.0759. [DOI] [PubMed] [Google Scholar]
  19. LILES W.C., LEDBETTER J.A., WALTERSDORPH A.W., KLEBANOFF S.J. Cross-linking of CD18 primes human neutrophils for activation of the respiratory burst in response to specific stimuli: implications for adhesion-dependent physiological responses in neutrophils. J Leukocyte Biol. 1995;58:690–697. doi: 10.1002/jlb.58.6.690. [DOI] [PubMed] [Google Scholar]
  20. LORANT D.E., PATEL K.D., MCINTYRE T.M., MCEVER R.P., PRESCOTT S.M., ZIMMERMAN G.A. Coexpression of GMP-140 and PAF by endothelium stimulated by histamine or thrombin: a juxtacrine system for adhesion and activation of neutrophils. J. Cell Biol. 1991;115:223–234. doi: 10.1083/jcb.115.1.223. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. LOWELL C.A., BERTON G. Integrin signal transduction in myeloid leukocytes. J. Leukocyte Biol. 1999;65:313–320. doi: 10.1002/jlb.65.3.313. [DOI] [PubMed] [Google Scholar]
  22. LOWELL C.A., FUMAGALLI L., BERTON G. Deficiency of Src family kinases P59/61hck and P58c-Fgr results in defective adhesion-dependent neutrophil functions. J. Cell Biol. 1996;133:895–910. doi: 10.1083/jcb.133.4.895. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. MOCSAI A., JAKUS Z., VANTUS T., BERTON G., LOWELL C.A., LIGETI E. Kinase pathways in chemoattractant-induced degranulation of neutrophils: the role of P38 mitogen-activated protein kinase activated by Src family kinases. J. Immunol. 2000;164:4321–4331. doi: 10.4049/jimmunol.164.8.4321. [DOI] [PubMed] [Google Scholar]
  24. MOCSAI A., LIGETI E., LOWELL C.A., BERTON G. Adhesion-dependent degranulation of neutrophils requires the Src family kinases Fgr and Hck. J. Immunol. 1999;162:1120–1126. [PubMed] [Google Scholar]
  25. MOCSAI A., ZHOU M., MENG F., TYBULEWICZ V.L., LOWELL C.A. Syk is required for integrin signaling in neutrophils. Immunity. 2002;16:547–558. doi: 10.1016/s1074-7613(02)00303-5. [DOI] [PubMed] [Google Scholar]
  26. NATHAN C., SANCHEZ E. Tumor necrosis factor and CD11/CD18 (Beta 2) integrins act synergistically to lower CAMP in human neutrophils. J. Cell Biol. 1990;111:2171–2181. doi: 10.1083/jcb.111.5.2171. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. NATHAN C., SRIMAL S., FARBER C., SANCHEZ E., KABBASH L., ASCH A., GAILIT J., WRIGHT S.D. Cytokine-induced respiratory burst of human neutrophils: dependence on extracellular matrix proteins and CD11/CD18 integrins. J. Cell Biol. 1989;109:1341–1349. doi: 10.1083/jcb.109.3.1341. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. NATHAN C.F. Neutrophil activation on biological surfaces. massive secretion of hydrogen peroxide in response to products of macrophages and lymphocytes. J. Clin. Invest. 1987;80:1550–1560. doi: 10.1172/JCI113241. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. OWEN C.A., CAMPBELL E.J. Neutrophil proteinases and matrix degradation. the cell biology of pericellular proteolysis. Semin. Cell Biol. 1995;6:367–376. doi: 10.1016/s1043-4682(05)80007-8. [DOI] [PubMed] [Google Scholar]
  30. RUCHAUD-SPARAGANO M.H., WALKER T.R., ROSSI A.G., HASLETT C., DRANSFIELD I. Soluble E-selectin acts in synergy with platelet-activating factor to activate neutrophil beta 2-integrins. Role of tyrosine kinases and Ca2+ mobilization. J. Biol. Chem. 2000;275:15758–15764. doi: 10.1074/jbc.M907390199. [DOI] [PubMed] [Google Scholar]
  31. SALAZAR E.P., ROZENGURT E. Bombesin and platelet-derived growth factor induce association of endogenous focal adhesion kinase with Src in intact Swiss 3T3 cells. J Biol Chem. 1999;274:28371–28378. doi: 10.1074/jbc.274.40.28371. [DOI] [PubMed] [Google Scholar]
  32. SCHLEIFFENBAUM B., MOSER R., PATARROYO M., FEHR J. The cell surface glycoprotein Mac-1 (CD11b/CD18) mediates neutrophil adhesion and modulates degranulation independently of its quantitative cell surface expression. J. Immunol. 1989;142:3537–3545. [PubMed] [Google Scholar]
  33. SHEIKH S., GRATZER W.B., PINDER J.C., NASH G.B. Actin polymerisation regulates integrin-mediated adhesion as well as rigidity of neutrophils. Biochem. Biophys. Res. Commun. 1997;238:910–915. doi: 10.1006/bbrc.1997.7407. [DOI] [PubMed] [Google Scholar]
  34. SMOLEN J.E., PETERSEN T.K., KOCH C., O'KEEFE S.J., HANLON W.A., SEO S., PEARSON D., FOSSETT M.C., SIMON S.I. L-selectin signaling of neutrophil adhesion and degranulation involves P38 mitogen-activated protein kinase. J. Biol. Chem. 2000;275:15876–15884. doi: 10.1074/jbc.M906232199. [DOI] [PubMed] [Google Scholar]
  35. STOCKS S.C., KERR M.A., HASLETT C., DRANSFIELD I. CD66-dependent neutrophil activation: a possible mechanism for vascular selectin-mediated regulation of neutrophil adhesion. J. Leukocyte Biol. 1995;58:40–48. doi: 10.1002/jlb.58.1.40. [DOI] [PubMed] [Google Scholar]
  36. TAKAMI M., HERRERA R., PETRUZZELLI L. Mac-1-dependent tyrosine phosphorylation during neutrophil adhesion. Am. J. Physiol. Cell Physiol. 2001;280:C1045–C1056. doi: 10.1152/ajpcell.2001.280.5.C1045. [DOI] [PubMed] [Google Scholar]
  37. VAN SPRIEL A.B., LEUSEN J.H., VAN EGMOND M., DIJKMAN H.B., ASSMANN K.J., MAYADAS T.N., VAN DE WINKEL J.G. Mac-1 (CD11b/CD18) is essential for Fc receptor-mediated neutrophil cytotoxicity and immunologic synapse formation. Blood. 2001;97:2478–2486. doi: 10.1182/blood.v97.8.2478. [DOI] [PubMed] [Google Scholar]
  38. VEDDER N.B., HARLAN J.M. Increased surface expression of CD11b/CD18 (Mac-1) is not required for stimulated neutrophil adherence to cultured endothelium. J. Clin. Invest. 1988;81:676–682. doi: 10.1172/JCI113372. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. WATERMAN W.H., MOLSKI T.F., HUANG C.K., ADAMS J.L., SHA'AFI R.I.Tumour necrosis factor-alpha-induced phosphorylation and activation of cytosolic phospholipase A2 are abrogated by an inhibitor of the P38 mitogen-activated protein kinase cascade in human neutrophils Biochem. J. 199631917–20.(Part 1) [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. YAN S.R., BERTON G. Antibody-induced engagement of beta2 integrins in human neutrophils causes a rapid redistribution of cytoskeletal proteins, Src-family tyrosine kinases, and P72syk that precedes de novo actin polymerization. J. Leukocyte Biol. 1998;64:401–408. doi: 10.1002/jlb.64.3.401. [DOI] [PubMed] [Google Scholar]
  41. YAN S.R., HUANG M., BERTON G. Signaling by adhesion in human neutrophils: activation of the P72syk tyrosine kinase and formation of protein complexes containing P72syk and Src family kinases in neutrophils spreading over fibrinogen. J. Immunol. 1997;158:1902–1910. [PubMed] [Google Scholar]
  42. YOUNG S.K., WORTHEN G.S., HASLETT C., TONNESEN M.G., HENSON P.M. Interaction between chemoattractants and bacterial lipopolysaccharide in the induction and enhancement of neutrophil Adhesion. Am. J. Respir. Cell Mol. Biol. 1990;2:523–532. doi: 10.1165/ajrcmb/2.6.523. [DOI] [PubMed] [Google Scholar]
  43. ZASLAVER A., FENIGER-BARISH R., BEN BARUCH A. Actin filaments are involved in the regulation of trafficking of two closely related chemokine receptors, CXCR1 and CXCR2. J. Immunol. 2001;166:1272–1284. doi: 10.4049/jimmunol.166.2.1272. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES